Endothelin and diabetic complications: a brain-centric view

Area of Science:

• Neuroscience
• Endocrinology
• Vascular Biology

Background:

• Diabetes is a global health concern with vascular complications.
• Diabetic vascular disease is a leading cause of death and disability.
• Cognitive impairment is a growing concern in diabetic patients, linked to cerebral small vessel disease.

Purpose of the Study:

• To review the role of the endothelin system in diabetes-related cerebrovascular dysfunction.
• To examine the impact of the endothelin system on cognitive impairment in diabetes.
• To provide a brain-centric perspective on endothelin's involvement in diabetic cerebrovascular disease.

Main Methods:

• Literature review focusing on the endothelin system (ET-1, ET(A), ET(B) receptors).
• Analysis of studies investigating diabetes, cerebrovascular disease, and cognitive function.
• Synthesis of evidence linking the endothelin system to diabetic brain complications.

Main Results:

• The endothelin system is implicated in various aspects of diabetic cerebrovascular disease.
• Endothelin signaling may contribute to small vessel disease in the diabetic brain.
• Dysregulation of the ET system is a potential mechanism for cognitive decline in diabetes.

Conclusions:

• The endothelin system is a key player in diabetes-associated cerebrovascular and cognitive dysfunction.
• Targeting the ET system may offer therapeutic strategies for preventing cognitive impairment in diabetics.
• Further research is needed to fully elucidate the ET system's role in diabetic encephalopathy.